Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Abay Bakytzhanuly , Tolegen Otegen , Omirbek Nuralinov Added: 1 year ago

Electrophysiology & Arrhythmia
Impact on Implantation Depth
Author(s): Verena Veulemans , Oliver Maier , Tobias Zeus Added: 2 years ago

Imaging & Diagnostics

Intervention
Conduction Abnormalities after TAVI: Incidence and Management Using MSCT
Author(s): Rutger-Jan Nuis , Mark van den Dorpel , Rik Adrichem , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery
EHRA 25: The SwissTAVI Registry
Author(s): Added: 12 months ago
EHRA 2025 - Long-term insights from pacemaker implantation after transcatheter aortic valve implantation (TAVI) show patients receiving pacemaker therapy within 30 days after TAVI had a significantly worse prognosis compared to patients with no pacemaker therapy in regards to all-cause death and CV death at one, five and ten year follow-ups.Prof Patrick Badertscher (University Hospital Basel,… View more

Electrophysiology & Arrhythmia

Intervention
Job title: Consultant Cardiologist
Dr Archana Rao serves as a Consultant Cardiologist at the Liverpool Heart and Chest Hospital. She is a heart failure specialist who performs complex device and lead extraction procedures in addition to leadless pacing, subcutaneous ICDs and His bundle pacing. Dr Rao has performed over 3,000 ICD implantations and over 500 system extractions, and she has implanted more than 1,500 permanent… View more
TAVI Linked to Lower 1-Year Mortality and Stroke Risk Versus SAVR in Low- to Intermediate-Risk Patients
Added: 7 months ago Source:  Transcatheter Academy
A large-scale meta-analysis suggests that for patients with severe symptomatic aortic stenosis (AS) at a low- to intermediate-surgical risk, transcatheter aortic valve implantation (TAVI) is associated with a lower risk of all-cause death or any stroke at one year compared with surgical aortic valve replacement (SAVR).¹This study was an individual participant data (IPD) meta-analysis of four… View more

Demographic

Electrophysiology & Arrhythmia
ESC 24 Hot Line Discussion: The RHEIA Trial
Author(s): Harriette Van Spall , Helene Eltchaninoff Added: 1 year ago
ESC Congress 2024 — Transcatheter aortic valve replacement shows superiority over surgical aortic valve replacement for women with severe aortic stenosis.Host, Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Helene Eltchaninoff (University Hospital of Rouen, FR) to discuss key findings from the RHEIA trial (NCT04160130; Optimapharm).This prospective, randomised study aims to… View more

Demographic

Intervention
LANDMARK: Myval THV Noninferior to Contemporary Valves
Added: 1 month ago Source:  Transcatheter Academy
One-year outcomes from the LANDMARK trial show the Myval transcatheter heart valve (THV) series is noninferior to contemporary THVs for treating symptomatic severe native aortic stenosis.¹ The results demonstrate comparable clinical efficacy and haemodynamic performance at 1 year.MethodologyLANDMARK (NCT04275726) was a prospective, randomised, open-label, noninferiority trial conducted across 31… View more

Demographic

Intervention
Choice of Transcatheter Aortic Valve Prosthesis
Author(s): Arif A Khokhar , Jonathan Curio , Matthew Hammond-Haley , et al Added: 4 months ago

Imaging & Diagnostics

Vascular Disease and Surgery